Skip to main content
. 2019 Jun;8(3):736–751. doi: 10.21037/tcr.2019.04.10

Table 4. Age distribution of gene-mutated patients.

Mutated genes ≥60 years <60 years
Cases Rate (%) Cases Rate (%)
EGFR 22 44.90 27 55.10
ALK 2 28.57 5 71.43
ROS1 3 75.00 1 25.00
MET 2 50.00 2 50.00
ERBB2 (Her2) 1 25.00 3 75.00
BRAF 1 50.00 1 50.00
KRAS 5 62.50 3 37.50